Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 200 / Carboplatin 2 / Gemcitabine 1000, Breast Cancer

Protocol-ID: 1933 V2.1 (Mini), PEMB200/CRBP2/GEMC1000, Breast Ca

Indication(s)

  • Breast Cancer (tripel negative); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 03.05.2024